Correction to: Nature Communications https://doi.org/10.1038/s41467-021-25066-9, published online 6 August 2021.
The original version of the Source Data file associated with this Article included an error in the ‘Fig. 6 and Supp Fig. 15 tab’, in which CD274 was inadvertently represented by a number series ranging from CD274 to CD300. The HTML has been updated to include a corrected version of Source Data; the original incorrect version of Source Data can be found as Supplementary Information associated with this Correction.
Author information
Authors and Affiliations
Consortia
Corresponding author
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Andres-Ejarque, R., Ale, H.B., Grys, K. et al. Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis. Nat Commun 12, 7358 (2021). https://doi.org/10.1038/s41467-021-27447-6
Published:
DOI: https://doi.org/10.1038/s41467-021-27447-6
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
